Adline Chem Lab shareholders and shareholding pattern
BSE: 524604Pharmaceuticals & BiotechnologySmall Cap
Last close ₹15.79₹0.00 (0.00%)
Share price at the BSE close on 12 Oct 2026. Previous close ₹15.79.
52-week range of traded prices to 12 Oct 2026
₹7.60Low, 3 Dec 2025₹16.21High, 13 Oct 2025
- Under BSE's graded surveillance, stage IV, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹9.24 Cr4,835th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Net worth zero or below
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business.
- Net worth zero or below
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- −685.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- Net worth zero or below
- Volume, BSEVolume. Shares traded on the last trading day.
- 2,500
Who owns Adline Chem Lab, filing by filing
Per cent of the company's shares. The last ten years of filings, from Dec 2016; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters25.85%
- Individuals and others74.15%
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Individuals and others
| Per cent | Dec 2016Filed 6 Jan | Mar 2017Filed 14 Apr | Jun 2017Filed 7 Jul | Sep 2017Filed 9 Oct | Dec 2017Filed 12 Jan | Mar 2018Filed 21 Apr | Jun 2018Filed 8 Jul | Sep 2018Filed 8 Oct | Dec 2018Filed 8 Jan | Mar 2019Filed 9 Apr | Jun 2019Filed 8 Jul | Sep 2019Filed 11 Oct | Dec 2019Filed 10 Jan | Mar 2020Filed 11 May | Jun 2020Filed 16 Jul | Sep 2020Filed 13 Oct | Dec 2020Filed 9 Jan | Mar 2021Filed 7 Apr | Jun 2021Filed 9 Jul | Sep 2021Filed 12 Oct | Dec 2021Filed 11 Jan | Mar 2022Filed 11 Apr | Jun 2022Filed 16 Jul | Sep 2022Filed 12 Oct | Dec 2022Filed 10 Jan | Mar 2023Filed 11 Apr | Jun 2023Filed 7 Jul | Sep 2023Filed 13 Oct | Dec 2023Filed 11 Jan | Mar 2024Filed 13 May | Jun 2024Filed 19 Jul | Sep 2024Filed 17 Oct | Dec 2024Filed 18 Jan | Mar 2025Filed 17 Apr | Jun 2025Filed 3 Sep | Sep 2025Filed 18 Oct | Dec 2025Filed 20 Jan | Mar 2026Filed 21 Apr | Jun 2026Filed 21 Jul | Sep 2026Filed 22 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 33.24% | 33.24% | 33.24% | 33.24% | 33.24% | 33.24% | 33.24% | 31.53% | 31.18% | 31.46% | 31.46% | 31.46% | 31.46% | 31.46% | 31.46% | 31.46% | 31.46% | 31.46% | 31.46% | 30.45% | 30.17% | 30.17% | 30.17% | 28.24% | 28.24% | 28.24% | 28.24% | 28.24% | 28.24% | 29.61% | 29.61% | 29.61% | 29.61% | 29.61% | 25.85% | 29.61% | 25.85% | 25.85% | 25.85% | 25.85% | |
| Indian promoters | 33.24% | 33.24% | 33.24% | 33.24% | 33.24% | 33.24% | 33.24% | 31.53% | 31.18% | 31.46% | 31.46% | 31.46% | 31.46% | 31.46% | 31.46% | 31.46% | 31.46% | 31.46% | 31.46% | 30.45% | 30.17% | 30.17% | 30.17% | 28.24% | 28.24% | 28.24% | 28.24% | 28.24% | 28.24% | 29.61% | 29.61% | 29.61% | 29.61% | 29.61% | 25.85% | 29.61% | 25.85% | 25.85% | 25.85% | 25.85% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 66.76% | 66.76% | 66.76% | 66.76% | 66.76% | 66.76% | 66.76% | 68.47% | 68.82% | 68.54% | 68.54% | 68.54% | 68.54% | 68.54% | 68.54% | 68.54% | 68.54% | 68.54% | 68.54% | 69.55% | 69.83% | 69.83% | 69.83% | 71.76% | 71.76% | 71.76% | 71.76% | 71.76% | 71.76% | 70.39% | 70.39% | 70.39% | 70.39% | 70.39% | 74.15% | 70.39% | 74.15% | 74.15% | 74.15% | 74.15% |
| Shares in issue | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 | 58,50,000 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. | 19,44,250 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Promoters' shares locked in | 19,44,250 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state.
Adline Chem Lab promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is Hemant Amrish Parikh, 25.85%.Promoter buying and selling
| Holder | ||
|---|---|---|
| Hemant Amrish ParikhIndividuals and Hindu undivided families | 25.85% | 15,12,440 |
No promoter shares are reported as pledged.
Largest public holders of Adline Chem Lab, filing by filing
Per cent, on the same shares as the split above.
| Holder | Dec 2016Filed 6 Jan | Mar 2017Filed 14 Apr | Jun 2017Filed 7 Jul | Sep 2017Filed 9 Oct | Dec 2017Filed 12 Jan | Mar 2018Filed 21 Apr | Jun 2018Filed 8 Jul | Sep 2018Filed 8 Oct | Dec 2018Filed 8 Jan | Mar 2019Filed 9 Apr | Jun 2019Filed 8 Jul | Sep 2019Filed 11 Oct | Dec 2019Filed 10 Jan | Mar 2020Filed 11 May | Jun 2020Filed 16 Jul | Sep 2020Filed 13 Oct | Dec 2020Filed 9 Jan | Mar 2021Filed 7 Apr | Jun 2021Filed 9 Jul | Sep 2021Filed 12 Oct | Dec 2021Filed 11 Jan | Mar 2022Filed 11 Apr | Jun 2022Filed 16 Jul | Sep 2022Filed 12 Oct | Dec 2022Filed 10 Jan | Mar 2023Filed 11 Apr | Jun 2023Filed 7 Jul | Sep 2023Filed 13 Oct | Dec 2023Filed 11 Jan | Mar 2024Filed 13 May | Jun 2024Filed 19 Jul | Sep 2024Filed 17 Oct | Dec 2024Filed 18 Jan | Mar 2025Filed 17 Apr | Jun 2025Filed 3 Sep | Sep 2025Filed 18 Oct | Dec 2025Filed 20 Jan | Mar 2026Filed 21 Apr | Jun 2026Filed 21 Jul | Sep 2026Filed 22 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sonal R BambhaniaResident individuals, over ₹2 lakh at face value | 1.14% | 1.14% | 1.14% | 1.14% | 1.14% | 1.14% | 1.14% | 1.14% | 1.14% | 1.14% | 1.14% | 1.14% | 1.14% | 1.14% | 1.14% | 1.14% | 1.14% | 1.14% | 1.14% | 1.14% | 1.14% | 1.14% | 1.14% | 1.14% | 1.14% | 1.14% | 1.14% | 1.14% | 1.14% | – | – | – | 1.14% | – | 1.14% | 1.14% | 1.14% | 1.14% | 1.14% | 1.14% |
| Yash Kashyap MehtaResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | 1.61% | 1.59% | 1.55% | 1.54% | 1.54% | 1.53% | 1.53% | 1.53% | 1.53% | 1.52% | 1.51% | 1.51% | 1.50% | 1.49% | 1.48% | 1.46% | 1.43% | 1.41% | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Yash K MehtaResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | 1.71% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.